The $6 million wallaby: push continues for homegrown genome project
06 November, 2003 by Melissa TrudingerIn what Francis Collins has termed "an unprecedented offer," the US NIH's National Human Genome Research Institute has offered to share the cost of generating the sequence of the tammar wallaby genome despite going ahead with an American opossum species as the chosen marsupial for comparative genomics.
Getting value from grid computing
05 November, 2003 by David BraueGrowing interest in grid computing technologies will drive its rapid advancement as the technology grows from research darling to commercial reality, IBM's senior grid computing strategist, Rob Vrablik, predicted during a recent visit to Sydney.
NZ's Protemix takes the road less travelled
05 November, 2003 by Graeme O'NeillProf Garth Cooper, CEO of Auckland biopharmaceutical company Protemix, aims to make his company the first New Zealand biotech to take a discovered compound all the way to market.
VPAC goes commercial to target start-ups' IT needs
04 November, 2003 by David BraueSmall companies within Australia's growing life sciences industry are starting to compute like the big boys, thanks to a growing investment in the sector by companies keen to feed its hunger for high-performance computing (HPC) systems.
INTERVIEW: Getting up to Speed
17 October, 2003 by Melissa TrudingerThe thing about bioinformatics, according to Prof Terry Speed, is that it tends to attract people from a variety of disciplines, such as physicists with programming skills not interested in a career in defence, or mathematicians with a practical bent.
New plea: just $5m needed for homegrown genome project
14 October, 2003 by Melissa TrudingerAustralia risks being left out in the cold if it doesn't participate in efforts to sequence the marsupial genome, say leading genomics scientists who are trying to raise AUD$5 million in support of Australian participation.
Criminalise human cloning, says new group
09 October, 2003 by Melissa TrudingerA newly-formed international consortium of scientists and lawyers has launched a bid to have human reproductive cloning declared a crime against humanity.
New ARC scheme aims to create research networks
02 October, 2003 by Melissa TrudingerThe Australian Research Council has launched a new program aimed at encouraging the development of research networks, and fostering interdisciplinary research.
ComBio: Unravelling the subtleties of telomerase
02 October, 2003 by Melissa TrudingerThe telomeres are intriguing repetitive structures found on the chromosome tips, which are responsible for preventing the gradual erosion of the ends of the chromosomes.
ComBio 2003: Proteomics provides shortcut around antibody shortage
30 September, 2003 by Melissa TrudingerA predicted shortfall in global production capabilities of monoclonal antibodies for therapeutic purposes has led Queensland researchers to look at ways of boosting production of the antibodies in cell lines.
AGT broadens patent to include cancer, heart disease
29 September, 2003 by Graeme O'NeillAGT Biosciences has filed to broaden the patent on its SelS gene, already a prime suspect in type 2 diabetes and inflammatory diseases, to cover heart disease, cancer infertility and other disorders.
Benitec appoints RNAi specialist to head US advisory board
18 September, 2003 by Tanya HollisBrisbane gene silencing company Benitec (ASX:BLT) has appointed a specialist in DNA-directed RNA interference to chair its scientific advisory board in the United States.
Gribbles enters biotech with genomics coup
17 September, 2003 by Tanya HollisPathology giant Gribbles (ASX:GGL) has announced a new subsidiary dedicated to biotechnology, with its first project being the development of a pre-natal screening test to detect genetic and chromosomal abnormalities.
Protemix aims to take NZ bio to market
12 September, 2003 by Graeme O'NeillProf Garth Cooper, CEO of Auckland biopharmaceutical company Protemix Corp, aims to make his company the first New Zealand biotech to take a discovered compound all the way to market.
CogState ponders market options
01 September, 2003 by Melissa TrudingerUnlisted Melbourne company CogState is contemplating a float on the Australian Stock Exchange, according to CEO Dr Peter Bick.
